Talks at GS
The pace of innovation in biotech: Mirador’s Mark McKenna
Mark McKenna is founder and CEO of Mirador Therapeutics, a company driving a new era in precision medicine for immune-mediated inflammatory and fibrotic diseases. He spoke with Dan Dees, co-head of Goldman Sachs Global Banking & Markets, about establishing a pace of innovation at Mirador that delivers novel medicines to patients faster. This session was filmed at our 2024 Builders and Innovators Summit.
Related Tags
Subscribe to Briefings
Our signature newsletter with insights and analysis from across the firm
By submitting this information, you agree that the information you are providing is subject to Goldman Sachs’ privacy policy and Terms of Use. You consent to receive our newletter via email.